Higher price of Covaxin in private markets needed to sustain costs: Bharat Biotech

Supply to the government of India at ₹150 per dose is a non-competitive price and clearly not sustainable in the long run, the company said

Comments

Popular posts from this blog

MUDA scam: Karnataka Lokayukta seeks more time to submit final report

Karnataka: BJP MLA used HIV positive women to honey trap rivals, probe launched

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation